$TARS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tarsus Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Tarsus Pharmaceuticals, Inc.. Get notifications about new insider transactions in Tarsus Pharmaceuticals, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | TARS | Tarsus Pharmaceuti ... | YARNO WENDY L | Director | Option Exercise | A | 35.26 | 5,000 | 176,300 | 5,000 | |
| Jun 17 2021 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | A | 35.26 | 10,000 | 352,600 | 10,000 | |
| Jun 17 2021 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | A | 35.26 | 10,000 | 352,600 | 10,000 | |
| May 07 2021 | TARS | Tarsus Pharmaceuti ... | RTW INVESTMENTS, LP | 10% Owner | Sell | S | 29.98 | 450,000 | 13,491,000 | 2,013,601 | 2.5 M to 2 M (-18.27 %) |
| Apr 16 2021 | TARS | Tarsus Pharmaceuti ... | Vivo Capital IX, LLC | 10% Owner | Sell | S | 30.37 | 400 | 12,148 | 3,244,635 | 3.2 M to 3.2 M (-0.01 %) |
| Mar 04 2021 | TARS | Tarsus Pharmaceuti ... | Holdbrook Mark J. | V.P., Clinical Affa ... | Option Exercise | A | 34.72 | 14,300 | 496,496 | 14,300 | |
| Feb 02 2021 | TARS | Tarsus Pharmaceuti ... | Wahl Bryan | General Counsel | Option Exercise | A | 37.44 | 89,368 | 3,345,938 | 89,368 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Greenstein Leonard M. | Chief Financial Off ... | Option Exercise | A | 47.25 | 40,999 | 1,937,203 | 40,999 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Neervannan Seshadri | Chief Operating Off ... | Option Exercise | A | 47.25 | 61,499 | 2,905,828 | 61,499 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Mottiwala Aziz | Chief Commercial Of ... | Option Exercise | A | 47.25 | 40,999 | 1,937,203 | 40,999 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Azamian Bobak R. | President and CEO | Option Exercise | A | 47.25 | 204,998 | 9,686,156 | 204,998 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Whitfield Dianne C. | Chief Human Resourc ... | Option Exercise | A | 47.25 | 89,368 | 4,222,638 | 89,368 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Azamian Bobak R. | President and CEO | Option Exercise | A | 47.25 | 204,998 | 9,686,156 | 204,998 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Whitfield Dianne C. | Chief Human Resourc ... | Option Exercise | A | 47.25 | 89,368 | 4,222,638 | 89,368 | |
| Nov 23 2020 | TARS | Tarsus Pharmaceuti ... | YARNO WENDY L | Director | Option Exercise | A | 23.40 | 20,000 | 468,000 | 20,000 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Option Exercise | C | 0.00 | 214,281 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,390,376 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 1,917,157 | 1.6 M to 1.9 M (+19.47 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | C | 0.00 | 214,281 | 0 | 1,604,657 | 1.4 M to 1.6 M (+15.41 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | C | 0.00 | 1,390,376 | 0 | 1,390,376 | 0 to 1.4 M |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 71,427 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 245,966 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 1,434,790 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 3,698 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 21,575 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | P | 16.00 | 168,750 | 2,700,000 | 1,920,933 | 1.8 M to 1.9 M (+9.63 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 71,427 | 0 | 1,752,183 | 1.7 M to 1.8 M (+4.25 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 245,966 | 0 | 1,680,756 | 1.4 M to 1.7 M (+17.14 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 1,434,790 | 0 | 1,434,790 | 0 to 1.4 M |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | P | 16.00 | 3,125 | 50,000 | 28,398 | 25.3 K to 28.4 K (+12.36 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 3,698 | 0 | 25,273 | 21.6 K to 25.3 K (+17.14 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 21,575 | 0 | 21,575 | 0 to 21.6 K |
Page: 1